The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.